Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Verve Therapeutics, Inc. (VERV)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
1 Dec 2022
Bellinger Andrew
CSO & CMO, Officer
Verve Therapeutics, Inc.
(VERV)
6,629
-11%
865
$22.95
$19,851.75
SELL
29 Nov 2022
Dorval Allison
Chief Financial Officer, Officer
Verve Therapeutics, Inc.
(VERV)
2,186
-20%
554
$22.10
$12,243.40
SELL
4 Nov 2022
GV 2017 GP, L.L.C.
Member of 10% Group
Verve Therapeutics, Inc.
(VERV)
893
-99%
97,166
$31.14
$3,025,611.00
SELL
4 Nov 2022
Yeshwant Krishna
Director, 10% Owner
Verve Therapeutics, Inc.
(VERV)
4,260,940
-1%
48,583
$31.14
$1,512,806.00
SELL
2 Nov 2022
GV 2017 GP, L.L.C.
Member of 10% Group
Verve Therapeutics, Inc.
(VERV)
27,290
-85%
156,440
$33.95
$5,310,658.00
SELL
2 Nov 2022
Yeshwant Krishna
Director, 10% Owner
Verve Therapeutics, Inc.
(VERV)
4,335,919
-1%
78,220
$33.95
$2,655,329.80
SELL
31 Oct 2022
GV 2017 GP, L.L.C.
Member of 10% Group
Verve Therapeutics, Inc.
(VERV)
2,637
-98%
171,319
$37.95
$6,501,031.00
SELL
31 Oct 2022
Yeshwant Krishna
Director, 10% Owner
Verve Therapeutics, Inc.
(VERV)
4,389,487
-1%
85,659
$37.95
$3,250,496.00
SELL
28 Oct 2022
Bellinger Andrew
CSO & CMO, Officer
Verve Therapeutics, Inc.
(VERV)
6,629
-60%
10,000
$39.90
$399,000.00
SELL
23 Sep 2022
Bellinger Andrew
CSO & CMO, Officer
Verve Therapeutics, Inc.
(VERV)
19,997
-75%
60,000
$35.34
$2,120,392.00
SELL
10 Aug 2022
Kathiresan Sekar
Chief Executive Officer, Director, Officer
Verve Therapeutics, Inc.
(VERV)
317,839
-13%
50,000
$29.90
$1,495,000.00
SELL
20 Jul 2022
Bellinger Andrew
CSO & CMO, Officer
Verve Therapeutics, Inc.
(VERV)
6,629
-75%
20,000
$34.90
$698,000.00
SELL
19 Jul 2022
Kathiresan Sekar
Chief Executive Officer, Director, Officer
Verve Therapeutics, Inc.
(VERV)
317,839
-13%
50,000
$29.90
$1,495,000.00
SELL
13 Jul 2022
Bellinger Andrew
CSO & CMO, Officer
Verve Therapeutics, Inc.
(VERV)
6,629
-60%
10,000
$24.90
$249,000.00
SELL
12 Jul 2022
FMR LLC
10% Owner, See Remark 1
Verve Therapeutics, Inc.
(VERV)
633,729
-20%
163,000
$20.78
$3,386,520.00
SELL
1 Jul 2022
FMR LLC
10% Owner, See Remark 1
Verve Therapeutics, Inc.
(VERV)
773,729
-4%
38,775
$15.66
$607,216.50
SELL
29 Jun 2022
FMR LLC
10% Owner, See Remark 1
Verve Therapeutics, Inc.
(VERV)
772,504
-6%
53,219
$15.45
$822,475.90
BUY
12 May 2022
ADELMAN BURT A
Director
Verve Therapeutics, Inc.
(VERV)
18,700
+114%
10,000
$12.15
$121,526.00
BUY
15 Mar 2022
ADELMAN BURT A
Director
Verve Therapeutics, Inc.
(VERV)
8,700
+85%
4,000
$21.38
$85,535.20
SELL
9 Mar 2022
FMR LLC
10% Owner, See Remark 1
Verve Therapeutics, Inc.
(VERV)
825,723
-0%
3,971
$29.01
$115,198.71
SELL
9 Feb 2022
FMR LLC
10% Owner, See Remark 1
Verve Therapeutics, Inc.
(VERV)
829,694
-1%
13,190
$29.46
$388,577.38
SELL
1 Feb 2022
FMR LLC
10% Owner, See Remark 1
Verve Therapeutics, Inc.
(VERV)
842,884
-4%
35,574
$29.04
$1,033,069.00
SELL
26 Jan 2022
FMR LLC
10% Owner, See Remark 1
Verve Therapeutics, Inc.
(VERV)
878,705
-15%
158,836
$31.12
$4,943,419.50
SELL
4 Jan 2022
Kathiresan Sekar
Chief Executive Officer, Director, Officer
Verve Therapeutics, Inc.
(VERV)
406,536
-0%
1,870
$39.90
$74,613.00
SELL
27 Dec 2021
Kathiresan Sekar
Chief Executive Officer, Director, Officer
Verve Therapeutics, Inc.
(VERV)
406,536
-10%
48,693
$40.16
$1,955,534.50
SELL
22 Dec 2021
Bellinger Andrew
Chief Scientific Officer, Officer
Verve Therapeutics, Inc.
(VERV)
18,032
-45%
15,000
$38.70
$580,469.00
SELL
22 Dec 2021
Kathiresan Sekar
Chief Executive Officer, Director, Officer
Verve Therapeutics, Inc.
(VERV)
406,536
-21%
114,000
$39.30
$4,480,604.00
BUY
2 Dec 2021
Ashe Andrew D.
See Remarks, Officer
Verve Therapeutics, Inc.
(VERV)
170,722
+2%
4,000
$32.10
$128,419.60
BUY
2 Dec 2021
ADELMAN BURT A
Director
Verve Therapeutics, Inc.
(VERV)
4,700
+100%
4,700
$31.34
$147,303.64
BUY
21 Jun 2021
Cormorant Asset Management, LP
Former 10% Owner
Verve Therapeutics, Inc.
(VERV)
984,224
+38%
275,000
$19.00
$5,225,000.00
BUY
21 Jun 2021
Rock Springs Capital Management LP
10% Owner
Verve Therapeutics, Inc.
(VERV)
926,298
+66%
370,000
$19.00
$7,030,000.00
BUY
21 Jun 2021
Casdin Partners Master Fund, L.P.
10% Owner
Verve Therapeutics, Inc.
(VERV)
2,417,596
+83%
1,100,000
$19.00
$20,900,000.00
BUY
21 Jun 2021
Redmile Group, LLC
10% Owner
Verve Therapeutics, Inc.
(VERV)
1,936,530
+118%
1,050,000
$19.00
$19,950,000.00
BUY
21 Jun 2021
Logos Global Management LP
10% Owner
Verve Therapeutics, Inc.
(VERV)
370,000
+100%
370,000
$19.00
$7,030,000.00
BUY
21 Jun 2021
Novo Holdings A/S
10% Owner
Verve Therapeutics, Inc.
(VERV)
793,265
+78%
350,000
$19.00
$6,650,000.00
BUY
17 Jun 2021
Beaudoin Margaret
Vice President, Finance, Officer
Verve Therapeutics, Inc.
(VERV)
1,000
+100%
1,000
$19.00
$19,000.00
BUY
17 Jun 2021
Bellinger Andrew
Chief Scientific Officer, Officer
Verve Therapeutics, Inc.
(VERV)
5,000
+100%
5,000
$19.00
$95,000.00
BUY
17 Jun 2021
Kathiresan Sekar
Chief Executive Officer, Director, Officer
Verve Therapeutics, Inc.
(VERV)
406,536
+0%
2,500
$19.00
$47,500.00
Home